Trial
NCT03757351
Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sanofi
Collaborators
Denali Therapeutics Inc.
Condition
Amyotrophic Lateral Sclerosis
Intervention
DNL747
Why stopped
Due to change in Sanofi's development strategy for DNL747/SAR443060 - not due to any safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-22